Safety and immunogenicity of COVID-19 vaccination in immunocompromised patients

The coronavirus disease 2019 (COVID-19) pandemic poses a great threat to public health. Individuals who are immunocompromised because of the progression of the primary disease or receiving immunosuppressive medications are prone to severe COVID-19 complications and poor outcomes. Abundant data have...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Jin-Wen, Hu, Wei, Shen, Lili, Wang, Fu-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945070/
https://www.ncbi.nlm.nih.gov/pubmed/36719354
http://dx.doi.org/10.1097/CM9.0000000000002505

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945070/
https://www.ncbi.nlm.nih.gov/pubmed/36719354
http://dx.doi.org/10.1097/CM9.0000000000002505

Ejemplares similares